Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants Nov 6, 2025 Life Science
U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245 Nov 6, 2025 Life Science
Beyond the Tech Titans: An AI Stock With a Different Kind of Disruption Nov 4, 2025 Life Science, Technology
Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle Nov 4, 2025 Life Science
Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month Nov 4, 2025 Life Science
Who Will Be the Next Winner in the Weight-Loss Drug Market? BioAge Labs Attracts Attention Oct 30, 2025 Life Science
With Yields Exceeding 5%, These Two High-Dividend Stocks Are Worth Watching Oct 29, 2025 Consumer Goods, Life Science
Trump’s Price-Cutting Vow Rattles Novo Nordisk, But Valuation and Pipeline Offer Compelling Case Oct 29, 2025 Life Science
Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential Oct 28, 2025 Life Science
It’s the Right Time for Vertex Pharmaceuticals to Look for Growth Drivers Beyond Tech Stocks Oct 27, 2025 Life Science
BioAge Labs Soars 46% on Novel Weight-Loss Drug Prospects, Yet Clinical Hurdles Remain Oct 26, 2025 Life Science
Why Can Eli Lilly Ignore Tariff Threats? Domestic Production Capacity and Gene Therapy Are Key Oct 24, 2025 Life Science
Navigating the Low Point: Can Moderna’s Innovative Pipeline Illuminate the Path Forward? Oct 23, 2025 Life Science
